The Future Revolution of Dadiah and Metformin to Repairing Gut Histopathology by Promoting IgA Expression of Diabetic Rats
DOI:
https://doi.org/10.48048/tis.2025.9331Keywords:
Probiotic, Dadiah, Metformin, Histopathology, IgA expressionAbstract
Diabetic nephropathy (DN) is often associated with problems in the digestive system. Many studies have shown that probiotics contained in Dadiah play a role in improving gut health. In addition, probiotics offer therapeutic benefits when combined with metformin. There doesn’t seem to be a study that looks at how Dadiah and metformin work together to improve the histopathology of the gut in a rat model of diabetes mellitus by raising the expression of immunoglobulin A (IgA). This study aimed to evaluate the synergistic effect between the combination of Dadiah and metformin in improving gut histopathology in a rat model of diabetes mellitus through increased expression of immunoglobulin A (IgA). This experimental study used adult Wistar Rattus norvegicus rats as the animal model. We randomly divided 35 rats into 7 treatment groups: 2 control groups and 5 treatment groups, each given a different combination of treatments. The Barthel-Manja score was used to determine what was wrong with 5 copies of each sample, and immunohistochemistry was used to determine how much IgA was in the gut tissue. Taking Dadiah and metformin together resulted in more IgA expression and significantly better intestinal histopathology scores compared to taking them separately. Combining Dadiah and metformin has the potential to usher in a new era in diabetes management. This is because both works together to improve the integrity of the intestinal epithelium by enhancing the mucosal immune response. This approach not only contributes to blood glucose control but also supports intestinal immune function, highlighting the potential of dietary intervention in comprehensive diabetes management.
HIGHLIGHTS
Using Dadiah and metformin together in a new way has shown tremendous promise in raising the level of IgA, which is an important part of the mucosal immune system. This combination shows promise as an effective adjuvant therapy for diabetic nephropathy (DN), offering new hope for patients with this condition.
GRAPHICAL ABSTRACT
Downloads
References
F Alam, M Nag, D Dasgupta and M Islam. Diabetic nephropathy: Risk factors and management. In: F Alam, R Amin, M Islam and J Yakin (Eds.). Pharmaceutical science: Research and innovation. Iterative International Publishers, Chikkamagaluru, India, 2024, p. 44-51.
SI Oktora and DB Butar. Determinants of diabetes mellitus prevalence in Indonesia. Jurnal Kesehatan Masyarakat 2022; 18(2), 266-273.
M Benkova-Petrova and S Staykova. Assessment of the clinical progression of diabetic kidney disease. Actual Nephrology 2023; 17(1), 21-27.
KK Kushwaha, U Kabra, R Dubey and J Gupta. Diabetic nephropathy: Pathogenesis to cure. Current Drug Targets 2022; 23(15), 1418-1429.
M Lee, H Zhao, X Liu, D Liu, J Chen, Z Li, S Chu, X Kou, S Liao, Y Deng, H Li and W Xie. Protective effect of hydroxysafflor yellow a on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat. Oxidative Medicine and Cellular Longevity 2020; 2020(1), 7805393.
H Shen and W Wang. Effect of glutathione liposomes on diabetic nephropathy based on oxidative stress and polyol pathway mechanism. Journal of Liposome Research 2021; 31(4), 317-325.
Y Yang, Y Wang, Z He, Y Liu, C Chen, Y Wang, DW Wang and H Wang. Trimetazidine inhibits renal tubular epithelial cells to mesenchymal transition in diabetic rats via upregulation of sirt1. Frontiers in Pharmacology 2020; 11, 1136.
P Portincasa, L Bonfrate, DQH Wang, G Frühbeck, G Garruti and A Di Ciaula. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract. European Journal of Clinical Investigation 2022; 52(11), e13846.
T Meldgaard and C Brock. Diabetes and the gastrointestinal tract. Medicine 2019; 47(7), 454-459.
R Mare and I Sporea. Gastrointestinal and liver complications in patients with diabetes mellitus - a review of the literature. Journal of Clinical Medicine 2022; 11(17), 5223.
J Paul and AVH Shihaz. Complications of gastrointestinal system in diabetes mellitus’- neglected part of diabetic management. Iranian Journal of Diabetes and Obesity 2020; 12(3), 164-173.
J Lunghar and AT Banu. Type 2 diabetes and gut health - narrative review. International Journal of Noncommunicable Diseases 2024; 9(1), 4-12.
Y Tong, S Liu, R Gong, L Zhong, X Duan and Y Zhu. Ethyl vanillin protects against kidney injury in diabetic nephropathy by inhibiting oxidative stress and apoptosis. Oxidative Medicine and Cellular Longevity 2019; 2019(1), 2129350.
J Xu, LQ Liu, LL Xu, Y Xing and S Ye. Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis. Clinical and Experimental Pharmacology and Physiology 2020; 47(4), 599-608.
S Sarkar, S Sadhu, R Roy, S Tarafdar, N Mukherjee, M Sil, A Goswami and NR Madhu. Contemporary drifts in diabetes management. International Journal of Applied Pharmaceutics 2023; 15(2), 1-9.
V Chaithanya, J Kumar, K Vajravelu Leela, M Ram and J Thulukanam. Impact of multistrain probiotic supplementation on glycemic control in type 2 diabetes mellitus - randomized controlled trial. Life 2024; 14(11), 1484.
Y Chen, X Shen, T Ma, X Yu, LY Kwok, Y Li, Z Sun, D Li and H Zhang. Adjunctive probio-X treatment enhances the therapeutic effect of a conventional drug in managing type 2 diabetes mellitus by promoting short-chain fatty acid-producing bacteria and bile acid pathways. mSystems 2023; 8(1), e01300-22.
BD Piccolo, JL Graham, P Kang, CE Randolph, K Shankar, L Yeruva, R Fox, MS Robeson, B Moody, T LeRoith, KL Stanhope, SH Adams and PJ Havel. Progression of diabetes is associated with changes in the ileal transcriptome and ileal‐colon morphology in the UC Davis Type 2 Diabetes Mellitus rat. Physiological Reports 2021; 9(22), e15102.
T Palacios, L Vitetta, S Coulson, CD Madigan, YY Lam, R Manuel, D Briskey, C Hendy, JN Kim, T Ishoey, MJ Soto-Giron, EM Schott, G Toledo and ID Caterson. Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: A randomised controlled pilot study. Nutrients 2020; 12(7), 2041.
IN Grigor’eva, TI Romanova, TS Suvorova and DL Nepomnyashchikh. Metformin and intestinal microbiota. Medicinskij Alfavit 2024; 26, 19-23.
X Li, Y Xia, X Song, Z Xiong, L Ai and G Wang. Probiotics intervention for type 2 diabetes mellitus therapy: A review from proposed mechanisms to future prospects. Critical Reviews in Food Science and Nutrition 2024. https://doi.org/10.1080/ 10408398.2024.2387765
Z Sun and C Dong. The application and research of probiotics in the treatment of diabetes. World Journal of Innovation and Modern Technology 2024; 7(5), 145-150.
H Memon, F Abdulla, T Reljic, S Alnuaimi, F Serdarevic, ZV Asimi, A Kumar and S Semiz. Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis. Diabetes Research and Clinical Practice 2023; 202, 110806.
DC Robbins, PJ Beisswenger, A Ceriello, RB Goldberg, RG Moses, EM Pagkalos, Z Milicevic, CA Jones, S Sarwat and MH Tan. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison. Clinical Therapeutics 2007; 29(11), 2349-2364.
F Patel, K Parwani, D Patel and P Mandal. Metformin and probiotics interplay in amelioration of ethanol-induced oxidative stress and inflammatory response in an in vitro and in vivo model of hepatic injury. Mediators of Inflammation 2021; 2021(1), 6636152.
R Amelia, FM Said, F Yasmin and H Harun. The potential of West Sumatran Dadiah as the novel to alleviate hyperglycemia, hypercholesterolemia, and reducing NF-kB expression in nephropathy diabetes rat model. Trends in Sciences 2023; 20(11), 6812.
N Fedchenko and J Reifenrath. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagnostic Pathology 2014; 9(1), 221.
M Barthel, S Hapfelmeier, L Quintanilla-Martínez, M Kremer, M Rohde, M Hogardt, K Pfeffer, H Rüssmann and WD Hardt. Pretreatment of mice with streptomycin provides a salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host. Infection and Immunity 2003; 71(5), 2839-2858.
N Fedchenko and J Reifenrath. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagnostic Pathology 2014; 9(1), 221.
OZ Lim, BS Yeoh, N Omar, M Mohamed, AAM Zin and R Ahmad. Stingless bee propolis, metformin, and their combination alleviate diabetic cardiomyopathy. Brazilian Journal of Pharmaceutical Sciences 2022; 58, e19652.
Y Sakar, B Meddah, MA Faouzi, Y Cherrah, A Bado and R Ducroc. Metformin-induced regulation of the intestinal D-glucose transporters. Journal of Physiology and Pharmacology 2010; 61(3), 301-307.
J Deng, L Zeng, X Lai, J Li, L Liu, Q Lin and Y Chen. Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activation. Journal of Cellular and Molecular Medicine 2018; 22(1), 546-557.
D Carter, HCS Howlett, NF Wiernsperger and CJ Bailey. Differential effects of metformin on bile salt absorption from the jejunum and ileum. Diabetes Obesity Metabolism 2003; 5(2), 120-125.
CB Lee, SU Chae, SJ Jo, UM Jerng and SK Bae. The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus. International Journal of Molecular Sciences 2021; 22(7), 3566.
PW Purnasari, T Nasihun and ST Zulaikhah. Effects of single or combined supplementation of probiotics and zinc on histological features of ileum, glucagon like peptide-1 and ghrelin levels in malnourished rats. Folia Medica 2021; 63(1), 59-66.
R Amelia, K Philip, YE Pratama and E Purwati. Characterization and probiotic potential of lactic acid bacteria isolated from dadiah sampled in West Sumatra. Food Science and Technology 2021; 41(S2), 746-752.
I Szymczak-Pajor, J Drzewoski, S Wenclewska and A Śliwińska. Metformin-associated gastrointestinal adverse events are reduced by probiotics: A meta-analysis. Pharmaceuticals 2024; 17(7), 898.
F Patel, K Parwani, P Rao, D Patel, R Rawal and P Mandal. Prophylactic treatment of probiotic and metformin mitigates ethanol-induced intestinal barrier injury: In vitro, in vivo, and in silico approaches. Mediators of Inflammation 2021; 2021(1), 5245197.
M Brīvība, L Silamiķele, I Kalniņa, I Silamiķelis, L Birzniece, L Ansone, L Jagare, I Elbere and J Kloviņš. Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance. Frontiers in Endocrinology 2023; 14, 1232143.
A Saito, J Kitayama, H Horie, K Koinuma, H Ohzawa, H Yamaguchi, H Kawahira, T Mimura, AK Lefor and N Sata. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Cancer Science 2020; 111(11), 4012-4020.
MV Maiorana. 2017, Analysis of the effects of metformin administered alone or in combined treatments in colorectal cancer. Ph. D. Dissertation. The Open University, Milton Keynes, United Kingdom.
AG Geagea, M Rizzo, A Jurjus, F Cappello, A Leone, G Tomasello, C Gracia, SA Kattar, L Massaad-Massade and A Eid. A novel therapeutic approach to colorectal cancer in diabetes: Role of metformin and rapamycin. Oncotarget 2019; 10(13), 1284-1305.
JH Fritz, OL Rojas, N Simard, DD McCarthy, S Hapfelmeier, S Rubino, SJ Robertson, M Larijani, J Gosselin, II Ivanov, A Martin, R Casellas, DJ Philpott, SE Girardin, KD McCoy, AJ Macpherson, CJ Paige and JL Gommerman. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 2012; 481(7380), 199-203.
S Yamasaki-Yashiki, Y Miyoshi, T Nakayama, J Kunisawa and Y Katakura. IgA-enhancing effects of membrane vesicles derived from Lactobacillus sakei subsp. sakei NBRC15893. Bioscience of Microbiota, Food and Health, 2019; 38(1), 23-29.
C Matsuzaki, K Kamishima, K Matsumoto, H Koga, T Katayama, K Yamamoto and K Hisa. Immunomodulating activity of exopolysaccharide -producing Leuconostoc mesenteroides strain NTM048 from green peas. Journal of Applied Microbiology 2014; 116(4), 980-989.
C Liu, Q Zhu, J Chang, Q Yin, A Song, Z Li, E Wang and F Lu. Effects of Lactobacillus casei and Enterococcus faecalis on growth performance, immune function and gut microbiota of suckling piglets. Archives of Animal Nutrition 2017; 71(2), 120-133.
CM Galdeano, AM de Leblanc, G Vinderola, MEB Bonet and G Perdigón. Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 2007; 14(5), 485-492.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
